Cargando…
A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare(®) System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease
PURPOSE: This study evaluated the safety and effectiveness of TearCare(®) System to treat the signs and symptoms of dry eye disease (DED). METHODS: In this multicenter, prospective, post-market, exploratory, interventional trial, 58 eyes (29 subjects) received a single TearCare procedure and were as...
Autores principales: | Karpecki, Paul, Wirta, David, Osmanovic, Smajo, Dhamdhere, Kavita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779309/ https://www.ncbi.nlm.nih.gov/pubmed/33408457 http://dx.doi.org/10.2147/OPTH.S285953 |
Ejemplares similares
-
A Comparison of TearCare and Lipiflow Systems in Reducing Dry Eye Disease Symptoms Associated with Meibomian Gland Disease
por: Holland, Edward J, et al.
Publicado: (2022) -
TearCare for the Treatment of Meibomian Gland Dysfunction in Adult Patients With Dry Eye Disease: A Masked Randomized Controlled Trial
por: Gupta, Preeya K., et al.
Publicado: (2022) -
TearCare(®) system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare(®) treatment on subjects with dry eye disease
por: Badawi, David
Publicado: (2019) -
A novel system, TearCare(®), for the treatment of the signs and symptoms of dry eye disease
por: Badawi, David
Publicado: (2018) -
Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye
por: Torkildsen, Gail, et al.
Publicado: (2017)